This paper describes 22 species of marine bryozoans found in the sand-grain-encrusting interstitial epifauna of the northeast coast of Sao Paulo state, Brazil: one new cyclostome, Disporella calcitrapa sp. nov., and 21 cheilostomes. Sixteen of the cheilostomes are new species, and three represent new genera. They are Ammatophora arenacea sp. nov., Discoporella gemmulifera sp. nov., Puellina caraguata sp. nov., Puellina tuba sp. nov., Rosulapelta rosetta gen. et sp. nov., Collarina spicata sp. nov., Hippothoa calcicola sp. nov., Trypostega ilhabelae sp. nov., Reptadeonella granulosa sp. nov., Drepanophora irregularis sp. nov., Allotherenia sabulosa gen. et sp. nov., Bryopesanser tilbrooki sp. nov., Psammocleidochasma tridentatum gen. et sp. nov., Celleporina abstrusa sp. nov., Hippoporella castellana sp. nov., and Hippoporella sabulonis sp. nov. Other species found in this habitat, Alderina smitti, Cymulopora uniserialis, Vibracellina laxibasis, Akatopora leucocypha, and Smittipora sawayai, have previously been described. The family Cymuloporidae fam. nov. is erected for Cymulopora and Crepis. The occurrence in this habitat of living colonies of bryozoans more characteristic of larger subtidal shell substrata indicates the potential importance of an interstitial refuge in maintaining and dispersing encrusting bryozoan populations along continental shelves where larger substrata are absent or rare.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11646/zootaxa.3710.2.1 | DOI Listing |
Sci Rep
January 2025
Department of Hematology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000, China.
A study in the Enshi Region between Sept-Nov 2023 assessed medical staff's knowledge, attitude, and practice regarding multiple myeloma. The disease significantly impacts physical health, quality of life, and mental well-being. Medical professionals play crucial roles in its prevention and treatment.
View Article and Find Full Text PDFMethods Enzymol
January 2025
Raymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv, Israel. Electronic address:
A-to-I RNA editing is an RNA modification that alters the RNA sequence relative to the its genomic blueprint. It is catalyzed by double-stranded RNA-specific adenosine deaminase (ADAR) enzymes, and contributes to the complexity and diversification of the proteome. Advancement in the study of A-to-I RNA editing has been facilitated by computational approaches for accurate mapping and quantification of A-to-I RNA editing based on sequencing data.
View Article and Find Full Text PDFCurr Top Dev Biol
January 2025
University of Michigan, Department of Pharmacology, Caswell Diabetes Institute, Ann Arbor, MI, United States. Electronic address:
All-trans retinoic acid (ATRA) signaling is essential in numerous different biological contexts. This review highlights the diverse roles of ATRA during development, function, and diseases of the pancreas. ATRA is essential to specify pancreatic progenitors from gut tube endoderm, endocrine and exocrine differentiation, and adult islet function.
View Article and Find Full Text PDFCurr Top Dev Biol
January 2025
Development, Aging, and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States. Electronic address:
All-trans RA (ATRA) is a small molecule derived from retinol (vitamin A) that directly controls gene expression at the transcriptional level by serving as a ligand for nuclear ATRA receptors. ATRA is produced by ATRA-generating enzymes that convert retinol to retinaldehyde (retinol dehydrogenase; RDH10) followed by conversion of retinaldehyde to ATRA (retinaldehyde dehydrogenase; ALDH1A1, ALDH1A2, or ALDH1A3). Determining what ATRA normally does during vertebrate development has been challenging as studies employing ATRA gain-of-function (RA treatment) often do not agree with genetic loss-of-function studies that remove ATRA via knockouts of ATRA-generating enzymes.
View Article and Find Full Text PDFLancet Diabetes Endocrinol
January 2025
LIB Therapeutics, Cincinnati, OH, USA. Electronic address:
Background: Lerodalcibep, a small binding anti-PCSK9 protein (adnectin), showed effective LDL cholesterol reduction in heterozygous familial hypercholesterolaemia. We aimed to assess the safety and efficacy of lerodalcibep and evolocumab in a globally diverse homozygous familial hypercholesterolaemia population.
Methods: This phase 3, randomised, open-label, crossover, non-inferiority study consisted of two 24-week treatment periods separated by an 8-week washout.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!